Vaccinex Yönetim
Yönetim kriter kontrolleri 3/4
Vaccinex's CEO is Maurice Zauderer, appointed in Apr 2001, has a tenure of 23.58 years. total yearly compensation is $430.28K, comprised of 95.7% salary and 4.3% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $10.64K. The average tenure of the management team and the board of directors is 15.8 years and 20.8 years respectively.
Anahtar bilgiler
Maurice Zauderer
İcra Kurulu Başkanı
US$430.3k
Toplam tazminat
CEO maaş yüzdesi | 95.7% |
CEO görev süresi | 23.6yrs |
CEO sahipliği | 0.1% |
Yönetim ortalama görev süresi | 15.8yrs |
Yönetim Kurulu ortalama görev süresi | 20.8yrs |
Son yönetim güncellemeleri
CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Jun 30 2024 | n/a | n/a | -US$18m |
Mar 31 2024 | n/a | n/a | -US$19m |
Dec 31 2023 | US$430k | US$412k | -US$20m |
Sep 30 2023 | n/a | n/a | -US$22m |
Jun 30 2023 | n/a | n/a | -US$22m |
Mar 31 2023 | n/a | n/a | -US$20m |
Dec 31 2022 | US$425k | US$401k | -US$20m |
Sep 30 2022 | n/a | n/a | -US$19m |
Jun 30 2022 | n/a | n/a | -US$20m |
Mar 31 2022 | n/a | n/a | -US$20m |
Dec 31 2021 | US$402k | US$375k | -US$22m |
Sep 30 2021 | n/a | n/a | -US$24m |
Jun 30 2021 | n/a | n/a | -US$28m |
Mar 31 2021 | n/a | n/a | -US$28m |
Dec 31 2020 | US$444k | US$357k | -US$29m |
Sep 30 2020 | n/a | n/a | -US$29m |
Jun 30 2020 | n/a | n/a | -US$28m |
Mar 31 2020 | n/a | n/a | -US$30m |
Dec 31 2019 | US$399k | US$347k | -US$32m |
Sep 30 2019 | n/a | n/a | -US$34m |
Jun 30 2019 | n/a | n/a | -US$33m |
Mar 31 2019 | n/a | n/a | -US$31m |
Dec 31 2018 | US$337k | US$337k | -US$30m |
Sep 30 2018 | n/a | n/a | -US$24m |
Jun 30 2018 | n/a | n/a | -US$24m |
Mar 31 2018 | n/a | n/a | -US$23m |
Dec 31 2017 | US$408k | US$328k | -US$22m |
Tazminat ve Piyasa: Maurice's total compensation ($USD430.28K) is below average for companies of similar size in the US market ($USD655.65K).
Tazminat ve Kazançlar: Maurice's compensation has increased whilst the company is unprofitable.
CEO
Maurice Zauderer (78 yo)
23.6yrs
Görev süresi
US$430,277
Tazminat
Dr. Maurice Zauderer, Ph.D. Co-Founded Vaccinex, Inc. in April 2001 and also serves as its President and Chief Executive Officer since April 2001. Dr. Zauderer serves as Director of Vaccinex Inc. since Apr...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Co-Founder | 23.6yrs | US$430.28k | 0.14% $ 10.6k | |
COO and Senior VP of Discovery & Translational Medicine | 3.5yrs | US$303.21k | 0.0018% $ 135.7 | |
Senior VP of Research & Chief Scientific Officer | 15.9yrs | US$308.90k | 0.0015% $ 115.0 | |
Chief Financial Officer | less than a year | Veri yok | Veri yok | |
Senior Vice President of Development | 15.8yrs | Veri yok | 0.00062% $ 47.5 |
15.8yrs
Ortalama Görev Süresi
52yo
Ortalama Yaş
Deneyimli Yönetim: VCNX's management team is seasoned and experienced (15.8 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Co-Founder | 23.6yrs | US$430.28k | 0.14% $ 10.6k | |
Independent Director | 19.9yrs | US$82.50k | 0% $ 0 | |
Independent Director | 21.7yrs | US$90.00k | 0.021% $ 1.6k | |
Scientific and Clinical Advisor | no data | Veri yok | Veri yok | |
Member of Scientific & Clinical Advisory Board | no data | Veri yok | Veri yok | |
Scientific and Clinical Advisor | no data | Veri yok | Veri yok | |
Scientific and Clinical Advisor | no data | Veri yok | Veri yok | |
Chairman of the Board | 23.6yrs | Veri yok | 0.081% $ 6.2k | |
Scientific & Clinical Advisor | no data | Veri yok | Veri yok | |
Scientific & Clinical Advisor | no data | Veri yok | Veri yok | |
Independent Director | 9.8yrs | US$85.00k | 0% $ 0 | |
Independent Lead Director | 9.8yrs | US$75.00k | 0.064% $ 4.9k |
20.8yrs
Ortalama Görev Süresi
77.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: VCNX's board of directors are seasoned and experienced ( 20.8 years average tenure).